Klisyri is an ointment used to treat adults with mild actinic keratosis on the face and scalp. Actinic keratosis is a precancerous, abnormal skin growth that develops after too much exposure to sunlight. Klisyri contains the active substance tirbanibulin. It is available as 250\-mg sachets, each containing 2\.5 mg of tirbanibulin.
Therapeutic Indication
Klisyri is indicated for the field treatment of non\-hyperkeratotic, non\-hypertrophic actinic keratosis (Olsen grade 1\) of the face or scalp in adults.
Therapeutic Area (MeSH)
ATC Code
D06BX03
ATC Item
N/A
Pharmacotherapeutic Group
Antibiotics and chemotherapeutics for dermatological use
Active Substance (Summary)
INN / Common Names
EMA Name
Klisyri
Medicine Name
Klisyri
Aliases
N/ANo risk management plan link.
